El FatimyRLiSChenZMushannenTGongalaSWeiZ and others. 2018. MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways. Acta Neuropathol136(4):537–55. https://doi.org/10.1007/s00401-018-1880-5
2.
LuikartBWBensenALWashburnEKPerederiyJVSuKGLiY and others. 2011. miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS One6(5):e19077. https://doi.org/10.1371/journal.pone.0019077
3.
Moreno-JiménezEPFlor-GarcíaMTerreros-RoncalJRábanoACafiniFPallas-BazarraN and others. 2019. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med25(4):554–60. https://doi.org/10.1038/s41591-019-0375-9
4.
NovakPKovacechBKatinaSSchmidtRScheltensPKontsekovaE and others. 2021. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease. Nat Aging 1:521–34. https://doi.org/10.1038/s43587-021-00070-2
5.
SaltaELauP Sala
FrigerioCCoolenMBally-CuifLDe StrooperB.2014. A self-organizing miR-132/Ctbp2 circuit regulates bimodal notch signals and glial progenitor fate choice during spinal cord maturation. Dev Cell 30(4):423–36. https://doi.org/10.1016/j.devcel.2014.07.006
6.
WalgraveHBalusuSSnoeckSVanden EyndenECraessaertsKThruppN and others. 2021. Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer’s disease. Cell Stem Cell. https://doi.org/10.1016/j.stem.2021.05.001. Epub May18.
